MedCerts to Expand Access to Healthcare and IT Career Training in New Partnership with Tier One Career and Technical Institute

LIVONIA, Mich., July 07, 2025 (GLOBE NEWSWIRE) — LIVONIA, Mich. – MedCerts, a Stride, Inc. company and a leader in online career training, is proud to announce a transformative new partnership with Tier One...

Collegium Announces $150 Million Share Repurchase Program

STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced its Board of...

JenaValve’s Trilogy™ THV System Procedures Live Broadcast at New York Valves 2025

IRVINE, Calif., July 07, 2025 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two...

Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025

MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management...

Medela Launches The Most Advanced Wearable Breast Pump: Magic InBra™ With FluidFeel Technology™ in Canada

Toronto, Canada, July 07, 2025 (GLOBE NEWSWIRE) — Medela, the brand trusted by millions of moms worldwide and the #1 brand in hospitals1, today announced the Canadian launch of Magic InBra™, the most advanced...

La Rosa Holdings Corp. Launches New Transaction Management Module, Intended to Deliver Significant Cost Savings and Operational Efficiencies

Celebration, FL, July 07, 2025 (GLOBE NEWSWIRE) — La Rosa Holdings Corp. (NASDAQ: LRHC) (“La Rosa” or the “Company”), a real estate and PropTech company, today announced the launch of My Agent Account Version 4.0,...

Apollo Names Brian Chu Head of Apollo Portfolio Performance Solutions

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Brian Chu has joined the firm as a Partner and Head of Apollo Portfolio Performance Solutions (APPS). In this role,...

Home Decor Brand Graham & Brown Boosts Operational Efficiency and Growth with BigCommerce

AUSTIN, Texas and LONDON, July 07, 2025 (GLOBE NEWSWIRE) — BigCommerce (Nasdaq: BIGC), a leading provider of open, composable commerce solutions for B2C and B2B brands, retailers, manufacturers and distributors, today announced that Graham...

UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) — UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has...

Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model

ART12.11, the Patented CBD:TMP Cocrystal, Demonstrates Potent Antidepressant-Like Activity and Cognitive Benefits Over Leading SSRI Data Being Presented at the 35thAnnual International Cannabinoid Research Society Symposium SOLANA BEACH, Calif., July 07, 2025 (GLOBE NEWSWIRE) —...

Camouflaged Cayenne Electric demonstrates performance and practicality

Atlanta., July 07, 2025 (GLOBE NEWSWIRE) — Worldwide testing of the new, all-electric Porsche Cayenne, which will join the existing Cayenne model line that includes hybrids and pure combustion engine models, is in full...

FTI Consulting Report: An Endgame for the Epic E-Commerce Era Is Within Sight

WASHINGTON, July 07, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the release of its 2025 U.S. Online Retail Report which projects e-commerce sales will hit $1.27 trillion in 2025, an...

Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria

 8 of 9 participants (89%) treated in the 240mg and 360mg single dose cohorts achieved a complete response 8 of 11 participants (73%) enrolled in the 180mg Q8W open label extension study achieved a...

Yiviva Presents Phase 2b Results for YIV-906 in Combination with Sorafenib in Advanced Hepatocellular Carcinoma at ASCO and ESMO GI 2025

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Yiviva, a clinical-stage biotechnology company pioneering systems biology-driven therapeutics, announced data from its multi-regional, randomized, double-blind, placebo-controlled Phase 2b study of sorafenib (SORA) with or without...

FuelCell Energy CEO Jason Few Applauds “One Big Beautiful Bill Act” as Catalyst for U.S. Clean Energy Leadership

DANBURY, Conn., July 07, 2025 (GLOBE NEWSWIRE) — FuelCell Energy, Inc. (Nasdaq: FCEL) President and CEO Jason Few has issued a statement praising the “One Big Beautiful Bill Act” (OBBBA) for its direct support...

Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)

LOUISVILLE, Ky., July 07, 2025 (GLOBE NEWSWIRE) — Onco360®, the nation’s leading independent specialty pharmacy, has added Augtyro™ (repotrectinib) manufactured by Bristol Myers Squibb to its comprehensive list of limited distribution therapies. Augtyro was...

Quipt Home Medical Acquires Healthcare System Owned Medical Equipment Provider with $6.6 Million in Revenue, and Signs Preferred Provider Agreement Covering 20 Hospitals Across 4 States

CINCINNATI, July 07, 2025 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (“Quipt” or the “Company”) (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced it...

Bluewave Nexor: This Bluewave Nexor App Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval

New York City, NY, July 07, 2025 (GLOBE NEWSWIRE) — As digital transformation continues to redefine global markets, Bluewave Nexor has emerged as one of the most talked-about innovations in AI-driven trading. At a time...

Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis

— Patients treated with bezuclastinib showed a superior mean change in total symptom score at 24 weeks (-24.3 points vs. -15.4 points, -8.91 point placebo-adjusted difference; p=0.0002), compared to patients treated with placebo, establishing...

The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region

– Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics –– Sale Price Included $8.3 Million Plus Regional Developer Rights that Generated $855,000 in Royalties and Franchise Fees over the 12 Months Ended...

New Business Book Unveils 17 Proven Rules to Save, Sustain, and Scale Struggling Companies

CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) — Veteran business leader and turnaround expert C. Joseph Incrocci announces the release of his newest book, 17 Powerful Rules That Will Save, Sustain, and Scale Your Business, now available on Amazon, Kindle,...

BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development

RESEARCH TRIANGLE PARK, N.C., July 07, 2025 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the appointment of Babar Ghias as chief financial officer (CFO) and head of corporate development. Mr. Ghias...

CORRECTION – Dr. Anosh Ahmed Announces Major Expansion of COVID Testing Contracts Across U.S. and International Markets

CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) — In a release issued under the same headline on June 25, 2025 11:00 ET by Dr. Anosh Ahmed, please note that the media contact should be Dr....

Tonix Pharmaceuticals Announces Oral Presentation on Mpox and Smallpox vaccine candidate TNX-801 at the Vaccine Congress 2025

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX-801 confers durable protection after a single dose TNX-801 is well tolerated in immunocompromised animals, without...

Denodo Announces Plans to Further Support AI Innovation by Releasing Denodo DeepQuery, a Deep Research Capability

PALO ALTO, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Denodo, a leader in data management, announced the availability of the Denodo DeepQuery capability, now as a private preview, and generally available soon, enabling generative...

Axsome Therapeutics to Showcase Its Innovative CNS Pipeline at Upcoming Frontiers in Brain Health R&D Day in New York City on July 21

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will...

Lexeo Therapeutics Announces FDA Breakthrough Therapy Designation for LX2006 in Friedreich Ataxia

Breakthrough Therapy designation based on interim clinical data from Phase I/II trials showing clinically meaningful improvements in cardiac biomarkers and functional measures LX2006 also selected for FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot...

Shoals Technologies Group, Inc. Announces Second Quarter 2025 Earnings Release Date and Conference Call

PORTLAND, Tenn., July 07, 2025 (GLOBE NEWSWIRE) — Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its second quarter 2025 results before market open on Tuesday, August...

Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference

LOS ALTOS, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced that Shalabh Gupta,...

OTC Markets Group Welcomes Vroom, Inc. to OTCQX

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Vroom, Inc. (“Vroom”) (OTCQX: VRMWW), a leading...

Flagship Communities Real Estate Investment Trust to Host Conference Call for Second Quarter 2025 Results

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, July 07, 2025 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (TSX: MHC.U) (TSX:MHC.UN) (“Flagship” or the “REIT”) today announced...

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

WARREN, N.J., July 07, 2025 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ:AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies,...

LYB to discuss second-quarter results Friday, August 1, 2025

HOUSTON and LONDON, July 07, 2025 (GLOBE NEWSWIRE) — LyondellBasell (NYSE: LYB), a leader in the global chemical industry, will announce its second-quarter 2025 financial results before the U.S. market opens Friday, August 1,...

Hyperscale Data Subsidiary Ault Markets Plans to Launch Solana Validator and Expand Blockchain Infrastructure Capabilities

LAS VEGAS, July 07, 2025 (GLOBE NEWSWIRE) — Hyperscale Data, Inc. (NYSE American: GPUS), a diversified holding company (“Hyperscale Data” or the “Company”), today announced that its indirect, wholly owned subsidiary, Ault Markets, Inc. (“Ault...

TBA Outdoors Rebrands to UNTAMED with Fierce New Identity

Charleston, SC, July 07, 2025 (GLOBE NEWSWIRE) — TBA Outdoors has officially revealed its boldest evolution yet – rebranding as Untamed. This isn’t just a name change; it’s a declaration of intent. Fueled by...

Ambow Unveils HybriU Knowledge Capture: Securing Organizational Knowledge for the Future

CUPERTINO, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Ambow Education Holding Ltd. (NYSE American: AMBO), a leading global provider of AI-driven education and collaboration technology, today announced the launch of HybriU Knowledge Capture, a...

Apogee Therapeutics Announces Positive 16-Week Data from Phase 2 APEX Clinical Trial of APG777, its Potentially Best-in-Class Anti-IL-13 Antibody, in Moderate-to-Severe Atopic Dermatitis

APEX Part A met all primary and key secondary endpoints and exceeded trial objectives, including 71.0% decrease from baseline in EASI at Week 16 APG777 demonstrated EASI-75 of 66.9% (42.5% placebo-adjusted) at Week 16, the...

CYCLACEL PHARMACEUTICALS ANNOUNCES AMENDMENT TO EXCHANGE AGREEMENT

Kuala Lumpur, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today announced that it has entered into an...

CYCLACEL PHARMACEUTICALS HIGHLIGHTS PUBLICATION OF PRECLINICAL DATA SHOWING THAT PLOGOSERTIB IS ACTIVE IN A HARD-TO-TREAT SUBTYPE OF LIVER CANCER

         – Fibrolamellar hepatocellular carcinoma (FLC) has no approved treatment and         occurs mostly in adolescents and young adults – KUALA LUMPUR, Malaysia, July 07, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP;...

AIBOT Welcomes White House Executive Order to Advance UAS Integration; AIBOT 500 to Make Public Premiere at Commercial UAV EXPO 2025

Next-generation UAV purpose-built for wildfire detection, emergency response, and middle-mile logistics to be showcased publicly for the first time at Commercial UAV EXPO 2025 in Las Vegas LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE)...

Vyond Achieves Official FedRAMP Authorization, Offering Secure Video Creation for the Government Sector

SAN MATEO, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Vyond, the effortless, all-in-one video creation platform, is now officially FedRAMP-authorized to operate and listed in the FedRAMP® marketplace at https://marketplace.fedramp.gov/products/FR2433985791. Thousands of federal agencies...

Lumissil Microsystems Expands Automotive Lighting Portfolio with Family of High-Side Linear LED Drivers

MILPITAS, Calif., July 07, 2025 (GLOBE NEWSWIRE) — Lumissil Microsystems announces the release of the IS32LT315x family, a new line of current-source linear LED drivers designed for automotive lighting applications, and Tail/Brake light combinations....

Sterling Trading Tech wins Best Listed Derivatives Trading Platform in APAC

Chicago , July 07, 2025 (GLOBE NEWSWIRE) — Sterling Trading Tech (Sterling), a leading provider of professional trading technology solutions, today announced that its trading platform has been named Best Listed Derivatives Trading Platform...

Best Delta 8 Gummies of 2025: Area 52 Named #1 Edible by Oregon Observer

Las Vegas, NV, July 06, 2025 (GLOBE NEWSWIRE) — In a landmark achievement that solidifies Area 52’s position as the Delta 8 market leader, The Oregon Observer’s extensive 2025 cannabis edibles review has awarded...

INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation Of Quantum Corporation (NASDAQ: QMCO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm

NEWTOWN, Pa., July 06, 2025 (GLOBE NEWSWIRE) — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Quantum Corporation (“Quantum”) (NASDAQ: QMCO), resulting from allegations of providing potentially misleading business...

Best THCA Vape of 2025 – Area 52 Named #1 Disposable by Oregon Observer

Las Vegas, NV, July 06, 2025 (GLOBE NEWSWIRE) — In a groundbreaking achievement that cements Area 52’s position as the premier innovator in cannabis vaping technology, The Oregon Observer’s comprehensive 2025 cannabis review has...

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Columbia University Customers Whose Data May Have Been Compromised

NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) — The law firm of Edelson Lechtzin LLP, based in suburban Philadelphia, is investigating data privacy claims regarding an incident at Columbia University (“Columbia”). Columbia learned of...

Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

SHELTON, Conn., July 06, 2025 (GLOBE NEWSWIRE) — Abinopharm, Inc., an innovative nutritional and biopharmaceutical company based in Shelton, Connecticut, USA, is pleased to announce that its partner, EGT Synbio, headquartered in Shanghai, China,...

Porsche 911 Club Coupe celebrates seven decades of Porsche Club of America

Oklahoma City., July 06, 2025 (GLOBE NEWSWIRE) — Third iteration of Porsche 911 Club Coupe for the PCA debuts at Porsche Parade Total of 70 units to be offered to PCA members Collaboration between...

Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025

SAN FRANCISCO and BOSTON, July 06, 2025 (GLOBE NEWSWIRE) — Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with the potential for differentiated efficacy and dosing in the largest inflammatory...

ROSEN, SKILLED INVESTOR COUNSEL, Encourages PepGen Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PEPG

NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PepGen Inc. (NASDAQ: PEPG) between March 7, 2024 and March 3, 2025,...